Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Gastric Cancer

Free Subscription Articles published in Br J Cancer Retrieve available abstracts of 44 articles: HTML format Text format

Single Articles

March 2018
1. XIN L, Yang WF, Zhang HT, Li YF, et al
   The mechanism study of lentiviral vector carrying methioninase enhances the sensitivity of drug-resistant gastric cancer cells to Cisplatin.
   Br J Cancer. 2018 Mar 26. pii: 10.1038/s41416-018-0043.
   PubMed     Text format     Abstract available
   
   
   
2. SHIMADA S, Akiyama Y, Mogushi K, Ishigami-Yuasa M, et al
   Identification of selective inhibitors for diffuse-type gastric cancer cells by screening of annotated compounds in preclinical models.
   Br J Cancer. 2018 Mar 12. pii: 10.1038/s41416-018-0008.
   PubMed     Text format     Abstract available
   
   
   February 2018
3. MIKI Y, Yashiro M, Okuno T, Kitayama K, et al
   CD9-positive exosomes from cancer-associated fibroblasts stimulate the migration ability of scirrhous-type gastric cancer cells.
   Br J Cancer. 2018 Feb 13. pii: bjc2017487. doi: 10.1038/bjc.2017.
   PubMed     Text format     Abstract available
   
   
   December 2017
4. WANG X, Zhao DB, Yang L, Chi Y, et al
   S-1 chemotherapy and intensity-modulated radiotherapy after D1/D2 lymph node dissection in patients with node-positive gastric cancer: a phase I/II study.
   Br J Cancer. 2017 Dec 12. pii: bjc2017424. doi: 10.1038/bjc.2017.
   PubMed     Text format     Abstract available
   
   
   November 2017
5. FANG C, Wang W, Feng X, Sun J, et al
   Nomogram individually predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms.
   Br J Cancer. 2017;117:1544-1550.
   PubMed     Text format     Abstract available
   
   
   October 2017
6. SEO AN, Kang BW, Kwon OK, Park KB, et al
   Intratumoural PD-L1 expression is associated with worse survival of patients with Epstein-Barr virus-associated gastric cancer.
   Br J Cancer. 2017 Oct 26. doi: 10.1038/bjc.2017.
   PubMed     Text format     Abstract available
   
   
   September 2017
7. GAYARRE J, Martin-Gimeno P, Osorio A, Paumard B, et al
   Characterisation of the novel deleterious RAD51C p.Arg312Trp variant and prioritisation criteria for functional analysis of RAD51C missense changes.
   Br J Cancer. 2017;117:1048-1062.
   PubMed     Text format     Abstract available
   
   
   
8. ALMEIDA GS, Panek R, Hallsworth A, Webber H, et al
   Pre-clinical imaging of transgenic mouse models of neuroblastoma using a dedicated 3-element solenoid coil on a clinical 3T platform.
   Br J Cancer. 2017;117:791-800.
   PubMed     Text format     Abstract available
   
   
   August 2017
9. JIMENEZ FONSECA P, Carmona-Bayonas A, Hernandez R, Custodio A, et al
   Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry.
   Br J Cancer. 2017 Aug 1. doi: 10.1038/bjc.2017.
   PubMed     Text format     Abstract available
   
   
   June 2017
10. SAMARENDRA H, Jones K, Petrinic T, Silva MA, et al
    A meta-analysis of CXCL12 expression for cancer prognosis.
    Br J Cancer. 2017;117:124-135.
    PubMed     Text format     Abstract available
    
    
    
11. KUROKAWA Y, Yang HK, Cho H, Ryu MH, et al
    Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach.
    Br J Cancer. 2017;117:25-32.
    PubMed     Text format     Abstract available
    
    
    
12. SIERZEGA M, Kaczor M, Kolodziejczyk P, Kulig J, et al
    Evaluation of serum microRNA biomarkers for gastric cancer based on blood and tissue pools profiling: the importance of miR-21 and miR-331.
    Br J Cancer. 2017 Jun 22. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available
    
    
    
13. ZHANG P, Tang WM, Zhang H, Li YQ, et al
    MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer.
    Br J Cancer. 2017 Jun 20. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available
    
    
    
14. CUSTODIO A, Carmona-Bayonas A, Jimenez-Fonseca P, Sanchez ML, et al
    Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab.
    Br J Cancer. 2017;116:1526-1535.
    PubMed     Text format     Abstract available
    
    
    April 2017
15. WENNERSTROM ECM, Simonsen J, Camargo MC, Rabkin CS, et al
    Acid-suppressing therapies and subsite-specific risk of stomach cancer.
    Br J Cancer. 2017;116:1234-1238.
    PubMed     Text format     Abstract available
    
    
    March 2017
16. PETRICK JL, Kelly SP, Liao LM, Freedman ND, et al
    Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies.
    Br J Cancer. 2017;116:951-959.
    PubMed     Text format     Abstract available
    
    
    
17. BAI T, Yokobori T, Altan B, Ide M, et al
    High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients.
    Br J Cancer. 2017 Mar 23. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available
    
    
    
18. SONG Y, Wang Y, Tong C, Xi H, et al
    A unified model of the hierarchical and stochastic theories of gastric cancer.
    Br J Cancer. 2017 Mar 16. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available
    
    
    February 2017
19. WANG Z, Koh WP, Jin A, Wang R, et al
    Composite protective lifestyle factors and risk of developing gastric adenocarcinoma: the Singapore Chinese Health Study.
    Br J Cancer. 2017;116:679-687.
    PubMed     Text format     Abstract available
    
    
    
20. LIANG X, Shi H, Yang L, Qiu C, et al
    Inhibition of polypyrimidine tract-binding protein 3 induces apoptosis and cell cycle arrest, and enhances the cytotoxicity of 5- fluorouracil in gastric cancer cells.
    Br J Cancer. 2017 Feb 21. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available
    
    
    January 2017
21. LI P, Chen H, Chen S, Mo X, et al
    Circular RNA 0000096 affects cell growth and migration in gastric cancer.
    Br J Cancer. 2017 Jan 12. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available
    
    
    December 2016
22. KODAMA H, Murata S, Ishida M, Yamamoto H, et al
    Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer.
    Br J Cancer. 2016 Dec 8. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available
    
    
    November 2016
23. OHASHI T, Komatsu S, Ichikawa D, Miyamae M, et al
    Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma.
    Br J Cancer. 2016 Nov 29. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available
    
    
    August 2016
24. MARTIN-ROMANO P, Sola JJ, Diaz-Gonzalez JA, Chopitea A, et al
    Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer.
    Br J Cancer. 2016 Aug 18. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available
    
    
    May 2016
25. WANG X, Zhao L, Liu H, Zhong D, et al
    A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer.
    Br J Cancer. 2016 May 12. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available
    
    
    
26. YOO C, Ryu MH, Na YS, Ryoo BY, et al
    Vorinostat in combination with capecitabine plus cisplatin as a first-line chemotherapy for patients with metastatic or unresectable gastric cancer: phase II study and biomarker analysis.
    Br J Cancer. 2016 May 12. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available
    
    
    April 2016
27. SONG D, Yue L, Li H, Zhang J, et al
    Diagnostic and prognostic role of serum protein peak at 6449 m/z in gastric adenocarcinoma based on mass spectrometry.
    Br J Cancer. 2016;114:929-38.
    PubMed     Text format     Abstract available
    
    
    March 2016
28. HACKER UT, Escalona-Espinosa L, Consalvo N, Goede V, et al
    Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trial.
    Br J Cancer. 2016 Mar 31. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available
    
    
    
29. TEBBUTT NC, Price TJ, Ferraro DA, Wong N, et al
    Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial.
    Br J Cancer. 2016;114:505-9.
    PubMed     Text format     Abstract available
    
    
    January 2016
30. LI Y, Gong J, Zhang Q, Lu Z, et al
    Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer.
    Br J Cancer. 2016;114:138-45.
    PubMed     Text format     Abstract available
    
    
    December 2015
31. KAWANAKA M, Watari J, Kamiya N, Yamasaki T, et al
    Effects of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic treatment: analysis of molecular alterations by a randomised controlled trial.
    Br J Cancer. 2015 Dec 15. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available
    
    
    
32. CHAN AW, Mercier P, Schiller D, Bailey R, et al
    H-NMR urinary metabolomic profiling for diagnosis of gastric cancer.
    Br J Cancer. 2015 Dec 8. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available
    
    
    
33. CAI J, Feng D, Hu L, Chen H, et al
    FAT4 functions as a tumour suppressor in gastric cancer by modulating Wnt/beta-catenin signalling.
    Br J Cancer. 2015 Dec 3. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available
    
    
    November 2015
34. DE SILVA N, Schulz L, Paterson A, Qain W, et al
    Molecular effects of Lapatinib in the treatment of HER2 overexpressing oesophago-gastric adenocarcinoma.
    Br J Cancer. 2015;113:1305-12.
    PubMed     Text format     Abstract available
    
    
    October 2015
35. KO YS, Cho SJ, Park J, Kim Y, et al
    Loss of FOXO1 promotes gastric tumour growth and metastasis through upregulation of human epidermal growth factor receptor 2/neu expression.
    Br J Cancer. 2015 Oct 8. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available
    
    
    September 2015
36. MA SH, Jung W, Weiderpass E, Jang J, et al
    Impact of alcohol drinking on gastric cancer development according to Helicobacter pylori infection status.
    Br J Cancer. 2015 Sep 17. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available
    
    
    
37. TOKUMOTO MW, Tanaka H, Tauchi Y, Kasashima H, et al
    Identification of tumour-reactive lymphatic endothelial cells capable of inducing progression of gastric cancer.
    Br J Cancer. 2015 Sep 10. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available
    
    
    August 2015
38. FEILCHENFELDT J, Varga Z, Siano M, Grabsch HI, et al
    Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2).
    Br J Cancer. 2015 Aug 27. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available
    
    
    
39. JI J, Jia S, Jia Y, Ji K, et al
    WISP-2 in human gastric cancer and its potential metastatic suppressor role in gastric cancer cells mediated by JNK and PLC-gamma pathways.
    Br J Cancer. 2015 Aug 20. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available
    
    
    July 2015
40. NATATSUKA R, Takahashi T, Serada S, Fujimoto M, et al
    Gene therapy with SOCS1 for gastric cancer induces G2/M arrest and has an antitumour effect on peritoneal carcinomatosis.
    Br J Cancer. 2015 Jul 16. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available
    
    
    June 2015
41. KASASHIMA H, Yashiro M, Nakamae H, Masuda G, et al
    Bone marrow-derived stromal cells are associated with gastric cancer progression.
    Br J Cancer. 2015 Jun 30. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available
    
    
    
42. CARDENAS-MONDRAGON MG, Torres J, Flores-Luna L, Camorlinga-Ponce M, et al
    Case-control study of Epstein-Barr virus and Helicobacter pylori serology in Latin American patients with gastric disease.
    Br J Cancer. 2015;112:1866-73.
    PubMed     Text format     Abstract available
    
    
    May 2015
43. CHEN XZ, Wang R, Hu JK
    Hepatitis B virus infection and gastric cancer risk: pitfalls in the potential association.
    Br J Cancer. 2015;112:1844.
    PubMed     Text format    
    
    
    
44. FORTUNATO L, Rushton L
    Stomach cancer and occupational exposure to asbestos: a meta-analysis of occupational cohort studies.
    Br J Cancer. 2015;112:1805-15.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: